𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis C in HIV-infected patients with and without AIDS: Prevalence and relationship to patient survival

✍ Scribed by Teresa L. Wright; Harry Hollander; Xiang Pu; Michael J. Held; Peter Lipson; Stella Quan; Alan Polito; M. Michael Thaler; Peter Bacchetti; Bruce F. Scharschmidt


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
441 KB
Volume
20
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Background: Limited information is available about the prevalence of hepatitis C virus in patients with human immunodeficiency virus in relation to specific risk factors or about the influence of hepatitis C virus coinfection on survival. This retrospective study addressed these questions. Methods: The study population consisted of 512 predominantly non-intravenous drug-using male homosexuals, 224 of whom had AIDS. Samples positive for hepatitis C virus antibody by second-generation enzyme immunoassay were further tested by means of strip immunoblot assay, and for hepatitis C virus RNA by means of polymerase chain reaction amplification. A randomly selected set of enzyme immunoassay-negative samples was also tested for hepatitis C virus RNA and, if hepatitis C virus RNA positive, by a second-generation recombinant immunoblot assay. Results: The prevalence of hepatitis C virus infection unaccounted for by intravenous drug use or transfusion was 11.7% by enzyme immunoassay, and 87% of sera positive by enzyme immunoassay were also positive by second-generation recombinant immunoblot assay or hepatitis C virus RNA analysis. Hepatitis C virus RNA was detectable in 53% of enzyme immunoassay-positive samples but in only about 1% of enzyme immunoassay-negative samples. Hepatitis C virus coinfection did not influence survival of HIV-infected patients with or without manifestations of AIDS. Conclusions: Hepatitis C virus infection in nontransfused, non-intravenous drugusing patients with HIV infection is several times more prevalent than in volunteer blood donors, suggesting homosexual transmission of hepatitis C virus. About


πŸ“œ SIMILAR VOLUMES


Prevalence and clinical significance of
✍ Paolo Fabris; Giulia Tositti; Maria Teresa Giordani; Luisa RomanΓ²; Corrado Bette πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 2 views

## Abstract Although hepatitis C virus (HCV) is a recognized cause of circulating cryoglobulins, the role of human immunodeficiency virus (HIV) in the pathogenesis of cryoglobulinemia has not been investigated extensively. To evaluate the prevalence of circulating cryoglobulins and to assess the re

Autoantibodies in human immunodeficiency
✍ Antonio Montero; Adria G. Giovannoni; Marcelo A. FernΓ‘ndez; Bernardo Pons-Estel; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 363 KB πŸ‘ 2 views

## Autoantibodies in human immunodeficiency virusinfected patients with and without concurrent hepatitis C infection Infections caused by human immunodeficiency virus (HIV) and hepatitis C virus (HCV), 2 blood-transmitted and frequently coinfecting agents, have been associated with autoantibody pr

Lamivudine resistance mutations in Europ
✍ Lucia Taramasso; Patrizia Caligiuri; Antonio Di Biagio; Bianca Bruzzone; Raffael πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 68 KB

## Abstract Evaluation of resistance pattern in patients with chronic hepatitis B. Retrospective study of hepatitis B virus (HBV) resistance mutations in patients found viraemic after first‐line treatment. HBV viral load was determined by a real‐time polymerase chain reaction and the substitutions

Prevalence of antibody to hepatitis C vi
✍ J. F. Quaranta; S. R. Delaney; S. Alleman; J. P. Cassuto; P. Dellamonica; J. P. πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 464 KB πŸ‘ 1 views

## Abstract The prevalence of antibody to hepatitis C virus (HCV) in a cohort of 272 HIV‐infected patients was assessed by means of 4 anti‐HCV assays: a 1st generation and a neutralization test, a 2nd generation test, and a confirmatory test, the dot‐blot Matrix HCVβ„’ immunoassay. The cohort include

Liver retransplantation of patients with
✍ Marwan Ghabril; Rolland C. Dickson; Victor I. Machicao; Jaime Aranda-Michel; And πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 260 KB πŸ‘ 1 views

Infection with hepatitis C virus (HCV) is the leading cause of liver transplantation (LT), while liver retransplantation (RT) for HCV is controversial as a result of concerns over poor outcomes. We sought to compare patient and graft survival after RT in patients with and without HCV. We performed a